References
- Matthis C, Bockmuhl U, Jahnke V, et al : Polymorphism in cytochrome P450, CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers : studies in upper aerodigestive tract cancers. Pharmacogenetics. 1998 ; 8 : 91-100
- Shin CS, Ahn KS, Tae K, et al : Genetic susceptibility of CYP1A1 and GSTM1 to the risk for Korean head and neck squamous cell carcinoma patients. Korean J Otolaryngol. 1999 ; 42 : 202-208
- Board PJ : Biochemical genetics of glutathione S-transferase in man. Am J Hum Genet. 1981 ; 33 : 36-43
- Board P, Coggan M, Johnston P, et al : Genetic heterogeneity of the human glutathione transferase : a complex of gene families. Pharmacol. 1990 ; 48 : 357-369
- Philip L, Sabina NS, Qing R, et al : p53, but not p16 mutations in oral squamous cell caricnomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use. Carcinogenesis. 1998 ; 19 : 509-514 https://doi.org/10.1093/carcin/19.3.509
- Dude Ophuis MB, van Kieshout EM, Roelofs HM, et al : Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer. 1998 : 81 : 936-943
- Nakachi K, Imai K, Hayashi S, et al : Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 1991 ; 51 : 5177-5180
- Alexandrie AK, Sundberg MI, Seidegard J, et al : Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1 : A study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 1994 ; 15 : 1785-1790 https://doi.org/10.1093/carcin/15.9.1785
- Ko KM, Ahn KS, Tea K, et al : Genetic polymorphism of cytochrome P4501Al exon 7 and glutathione S-transferase M1 in the head and neck squamous cell carcinoma patients. Korean J Otolaryngol. 1999 ; 42 : 1405-1412
- Watson MA, Stewart RK, Smith BJ, et al : Human glutathione S-transferase P1 polymorphisms relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis (Lond.). 1995 ; 16 : 2125-2128
- Harris AL : Mutant p53-the commonest genetic abnormality in human cancer? J pathol. 1990 ; 162 : 5-6
- Kawajiri K, Eguchi H, Nakachi K, et al : Association of CYPIA1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res. 1996 ; 56 : 72-76
- Jeffrey E, McWilliams, Adam JE, Tomasz MB, et al : Genetic polymorphisms in head and neck cancer risk. Head Neck. 2000 ; 22 :609-617 https://doi.org/10.1002/1097-0347(200009)22:6<609::AID-HED10>3.0.CO;2-L
- Mark Welfare, A. Monesola Adeokun, Margaret F. Bassendine, Ann K. Daly: Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention. 1999 ; 8 : 289-292
- Hayashi S, Watanabe J, Nakachi K, Kawajiri K : Genetic linkage of lung cancer-associated Msp I polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501 IAl gene. J Biochem. 1991 ; 110 : 407-411
- Kihara M, Noda K : Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYPIAI and GSTM1 gene polymorphisms in a Japanes population. Carcinogenesis. 1995 ; 16 : 2331-2336 https://doi.org/10.1093/carcin/16.10.2331
- Comstock KE, Sanderson BJ, Claflin G, Heuner WD : GSTM1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res. 1990 ; 18 : 3670
- Warwick A, Sarhauis P, Redman G, et al : Theta class glutathione S-transferase GSTTI genotypes and susceptibility to cervical neoplasia: Interactions with GSTMl, CYP2D6 and smoking. Carcinogenesis. 1994 ; 15 : 2841-2845 https://doi.org/10.1093/carcin/15.12.2841
- Matthias C, Bockmuhl U, Jahnke V, et al : The glutathione Stransferase GSTP1 polymorphism : effects on susceptubility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics. 1998;8 :1-6 https://doi.org/10.1097/00008571-199802000-00001
- Rebbeck TR : Molecula epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTTI in cancer susceptibility. Cancer Epidemiol. Biomark. Prevo 1997 ; 6 : 733-743
- Park JY, Stimson P. Schantz, Jordan C. Stem, et al : Association between glutathione Saransferase IT genetic polymorphisms and oral canper risk. Pharmarcogenetics. 1999 ; 9 : 497-504
- Oude Ophuis MB, van Kieshout EM, Roelofs HM, et al : Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphism in relation to the risk for benign and malignant head and neck lesions. Cancer. 1998 ; 82 (5) : 936-943 https://doi.org/10.1002/(SICI)1097-0142(19980301)82:5<936::AID-CNCR20>3.0.CO;2-0
- Choi G, Lee JS, Yoo DH, et al : p53 mutation patterns in primary head and neck squamous cell carcinomas and their metastatic neck nodes. Korean J Otolaryngol. 1998 ; 41 : 906-912
- Field JK, Spandidos DA, Malliri A : Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma ofhead and neck. Br J Cancer. 1991 ; 64 : 573-581 https://doi.org/10.1038/bjc.1991.352
- Boyle JO, Hakim J, Koch W, et al : The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993 ; 53 : 4477-4480
- Kihara M, Kubota A, Fumkawa M, Kimura H : GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Letters. 1997 ; 12 : 257-262
- Greenbalt MS, Bennett WP,Hollstein M, Harris CC : Mutations in the p53 tumor suppressor gene ; Clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994 ; 54 : 4855-4878